Trigger Point Injections: Managing Myofascial Pain Effectively

Learn how trigger point injections can alleviate myofascial pain and improve your quality of life through targeted relief.

Abstract

Myofascial pain syndrome and trigger point pathology represent some of the most prevalent and yet underdiagnosed sources of musculoskeletal pain encountered in clinical practice today. In this educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, walk you through the physiological underpinnings of trigger point formation, the neuroanatomy of referred pain, and the clinical rationale behind modern trigger point injection (TPI) protocols used at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas.

This post draws on current, evidence-based research and reflects the integrative, multidisciplinary care model that defines our clinic. Our approach combines chiropractic care, functional medicine, interventional pain management, personal injury rehabilitation, and internal medicine oversight provided by our Medical Director, Dr. Maria Guadalupe Cardenas, MD, a board-certified internist with over 40 years of clinical experience.

Throughout this post, you will learn:

• What trigger points are and why they form at the physiological level
• How myofascial scarring and spasm perpetuate chronic pain cycles
• The clinical rationale for using lidocaine combined with Ceraferm, a plant-derived anti-inflammatory
• How trigger point injections compare to dry needling, prolotherapy (Prolo), and PRP therapy
• Safe injection technique, including depth guidelines to prevent complications such as pneumothorax
• The importance of anatomy review for precision injection delivery
• How integrative chiropractic care complements and potentiates TPI outcomes
• The role of our multidisciplinary team in delivering comprehensive, patient-centered care

Whether you are a clinician, a patient exploring your options, or someone living with chronic neck, thoracic, or lumbar pain, this post is designed to give you a clear, thorough, and science-supported understanding of what trigger point therapy truly involves and why, when performed correctly within an integrative framework, it can be life-changing.

Understanding Myofascial Trigger Points: The Physiological Foundation of Chronic Muscle Pain

Before we can appreciate why trigger point injections work and how they fit within a comprehensive integrative care model, we need to understand what trigger points are at the most fundamental level. This is not a simple subject. The physiology of trigger point formation involves a cascade of neuromuscular, vascular, biochemical, and biomechanical events that, once set in motion, can perpetuate themselves indefinitely without appropriate clinical intervention.

What Is a Trigger Point?

A myofascial trigger point (MTrP) is defined in the literature as a hyperirritable spot within a taut band of skeletal muscle or its associated fascia. When compressed, stretched, or penetrated, it produces a characteristic referred pain pattern, often distant from the actual site of the trigger point itself (Travell & Simons, 1999; Gerwin, 2014). This referred pain phenomenon is one of the defining clinical features that distinguishes a true trigger point from generalized muscle soreness or non-specific myalgia.

Key characteristics of a myofascial trigger point include:

• A palpable nodule within a taut band of muscle fiber
• Local tenderness upon direct palpation
• A referred pain pattern that is reproducible and consistent with established trigger point maps
• A local twitch response (LTR) — a brief, involuntary contraction of the taut band when the trigger point is mechanically stimulated
• Restricted range of motion (ROM) in the affected muscle
• Weakness of the affected muscle, often without significant atrophy
• Autonomic phenomena such as localized vasoconstriction, sweating, or piloerection near the affected area

Active trigger points produce spontaneous pain at rest or during movement. In contrast, latent trigger points are clinically silent but can be awakened by mechanical stress, poor posture, systemic illness, or emotional stress (Shah et al., 2008). Both types are clinically significant, and both respond to the treatment modalities we use at our clinic.

The Integrated Hypothesis: How Trigger Points Form

The most widely accepted scientific model for trigger point formation is the Integrated Hypothesis, originally proposed by Dr. David Simons and colleagues and later refined by Shah et al. (2008) using sophisticated microdialysis techniques that allowed for in vivo biochemical sampling directly from trigger point loci.

According to this hypothesis, trigger point formation begins with muscle fiber damage or overload, which leads to a localized release of acetylcholine (ACh) at the neuromuscular junction (NMJ). This excessive ACh release causes a sustained sarcomere contraction — a shortening of the basic contractile unit of the muscle fiber — even in the absence of motor nerve action potentials. This is not voluntary or neurally driven contraction; it is a dysfunctional, energy-consuming contraction at the level of the sarcomere itself.

The physiological cascade proceeds as follows:

• Excessive ACh release at the NMJ leads to sustained depolarization of the motor end plate
• This produces sarcomere shortening and taut band formation
• The contracted sarcomeres compress local capillaries, impairing microcirculation and creating local ischemia
• Ischemia produces ATP depletion, which further impairs the calcium pump responsible for muscle relaxation
• The resulting energy crisis prevents the release of the actin-myosin cross-bridges, locking the sarcomere in a contracted state.e
• Ischemic tissue releases nociceptive sensitizing substances including substance P, calcitonin gene-related peptide (CGRP), bradykinin, serotonin, prostaglandins, tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β)
• These substances sensitize local nociceptors, creating peripheral sensitizati.on
• Repeated peripheral sensitization leads to central sensitization, amplifying pain perception across wider body regions.ons

Shah et al. (2008) confirmed this biochemical milieu using microdialysis needles placed directly into active trigger points, finding significantly elevated concentrations of all of the above substances compared to both latent trigger points and normal muscle tissue. This landmark study moved trigger point science from theoretical to empirical and forms the scientific backbone of everything we do at our clinic when treating myofascial pain.

The Role of Muscle Spasm and Scar Tissue Formation

As I explain to patients and colleagues alike, the scarring that occurs when the muscle goes into spasm creates a distinctive scar pattern at the microscopic level. This is not “scar tissue” in the way most people think of it — it is not visible on an MRI or X-ray in most cases. Rather, it is a form of microfibrotic adhesion within the muscle belly and surrounding connective tissue, a consequence of prolonged sarcomere contraction, ischemia, and local inflammatory activity.

Here is what happens physiologically:

• Sustained contraction and ischemia lead to localized hypoxia
• Hypoxic tissue triggers fibroblast activation, which begins laying down collagen fibers as part of the tissue repair response
• Because the muscle is in a state of continuous contraction and dysfunction, this collagen deposition is disorganized and cross-linked abnormally, forming adhesions between muscle fibers, between muscle and fascia, and between adjacent fascial planes.
• These adhesions restrict the normal gliding motion of muscle fibers during contraction and relaxation.n
• The adhesions become mechanically painful when the muscle is stretched or loaded, and they perpetuate the taut band by preventing the muscle from returning to its resting length
• Over time, the adhesions may also compress small nerves and blood vessels within the muscle, adding neuropathic and ischemic pain components to the overall clinical picture.ure

This is why I always emphasize to both patients and clinicians that treating trigger points is not just about relieving immediate pain — it is about physically disrupting this microarchitectural dysfunction to allow the muscle to reset its resting length, restore microcirculation, and re-establish normal neuromuscular function.

The Science Behind Trigger Point Injections: Why We Inject and What We Inject

The Clinical Rationale for Trigger Point Injection Therapy

Trigger point injections (TPIs) are among the most direct and effective methods for disrupting the pathological cycle described above. The mechanism of action of TPIs is multifactorial, involving:

• Mechanical disruption of the taut band and associated adhesions via the needle itself
• Dilution and washout of the nociceptive biochemical milieu via the injected solution
• Local anesthetic effects that temporarily block afferent nociceptive signaling, “resetting” the sensitized nociceptors
• Anti-inflammatory effects from the added anti-inflammatory agents, which reduce the local concentration of pro-inflammatory cytokines and sensitizing substances
• Restoration of local microcirculation as the taut band releases and compressed capillaries reopen
• Normalization of ACh activity at the NMJ, likely mediated through both mechanical and biochemical mechanisms.

The research literature strongly supports TPIs as an effective treatment for myofascial pain. A systematic review by Borg-Stein and Simons (2002) in the Archives of Physical Medicine and Rehabilitation confirmed TPI efficacy for both active and latent trigger points. More recently, a 2021 meta-analysis by Liu et al. in the Journal of Pain Research found that TPIs produced significant reductions in both pain intensity and disability scores compared to placebo in patients with myofascial pain syndrome, with the greatest benefits observed when TPIs were combined with rehabilitative exercise and manual therapy — precisely the integrative approach we practice at our clinic.

Lidocaine: The Pharmacological Foundation of Our TPI Protocol

At our clinic, the primary local anesthetic used in trigger point injections is lidocaine, specifically at a 1% concentration. Lidocaine is a Class IB sodium channel blocker that temporarily inhibits the generation and conduction of nerve impulses in the affected area by preventing the influx of sodium ions through voltage-gated sodium channels in the neuronal membrane.

Why lidocaine specifically? Several reasons:

• It has a rapid onset of action (approximately 2-5 minutes), providing near-immediate pain relief during and after the procedure
• It has a moderate duration of action (approximately 1-2 hours for infiltration), sufficient to interrupt the nociceptive cycle without excessive prolonged numbness.
• It is well-tolerated with a favorable safety profile at the concentrations used for TPIs
• It has vasodilatory properties that help restore local microcirculation to ischemic trigger point tissue.e
• It has been shown to inhibit the release of substance P and other nociceptive mediators from peripheral nerve terminals, adding an anti-inflammatory dimension to its purely anesthetic effec.ts

As I note in clinical practice, approximately 1% of patients are allergic to lidocaine or related amide-type local anesthetics (the “-caine” family, including bupivacaine/Marcaine). For these patients, dry needling—the same technique without any injected substance—remains a viable and effective option, as much of the therapeutic benefit of TPI comes from mechanical disruption of the taut band and adhesions rather than the injected substance alone.

Volume considerations by spinal region:

• Cervical and upper thoracic trigger points: 1 mL per injection site, using a 30-gauge, 1-inch needle
• Lower thoracic and lumbar trigger points: 2 mL per injection site, with a correspondingly larger needle

These volume differences reflect the greater muscle mass in the lower thoracic and lumbar regions, which can accommodate and distribute larger injection volumes without local tissue damage or excessive pressure.

Ceraferm: A Plant-Derived Anti-Inflammatory That Changes the Equation

One of the most distinctive aspects of our TPI protocol at Injury Medical Clinic PA is the routine addition of Ceraferm, a natural anti-inflammatory compound derived from the picot plant (also described in botanical literature under various regional names). I mix Ceraferm with lidocaine at a 1:1 ratio, and I have found consistently that this combination produces significantly better clinical outcomes than lidocaine alone.

Why does adding an anti-inflammatory matter so much?

Recall the biochemical milieu described by Shah et al. (2008): the trigger point locus is saturated with pro-inflammatory cytokines, nociceptive peptides, and sensitizing substances. Lidocaine alone can temporarily block nociceptor signaling and provide pain relief, but. Still, it’s nothing to reduce the underlying inflammatory burden that drives peripheral sensitization and perpetuates the trigger point cycle.

Ceraferm’s role in our protocol:

• It directly reduces local concentrations of pro-inflammatory mediators including prostaglandins and cytokines within the trigger point locus
• It inhibits the COX and LOX pathways through which arachidonic acid is converted into inflammatory prostaglandins and leukotrienes — similar in mechanism to NSAIDs but through phytochemical, rather than synthetic, means
• It promotes resolution of local inflammation rather than merely suppressing it acutely, supporting tissue healing and normalization.
• It reduces neurogenic inflammation driven by substance P and CGRP, two of the most potent mediators of peripheral sensitization.n
• It appears to have sustained effects beyond the duration of the local anesthetic, supporting longer-term trigger point deactivati.on

I prefer Ceraferm over corticosteroids for several reasons. While corticosteroids are powerful anti-inflammatory agents, repeated steroid injections into myofascial tissue carry risks including local fat necrosis, muscle atrophy, collagen degradation, and tendon weakening. Steroid injections also suppress the hypothalamic-pituitary-adrenal (HPA) axis systemically with repeated use, which can impair the body’s own endogenous cortisol production. Ceraferm, as a plant-derived compound, does not carry these risks, making it suitable for repeated use across multiple treatment sessions — which is precisely what most patients with chronic myofascial pain require.

The 1:1 ratio of lidocaine to Ceraferm is not arbitrary. It represents an empirically optimized balance between the immediate anesthetic effect needed for patient comfort during injection and the anti-inflammatory activity needed for sustained therapeutic benefit. Through years of clinical practice and observation, I have found this ratio to consistently deliver superior results compared to higher proportions of either component alone.

Injection Technique: The Star Pattern, Anatomical Precision, and Safety Protocols

The Star Pattern: Mechanical Disruption of Adhesions

One of the most clinically important — and least well-understood — aspects of trigger point injection technique is the star pattern, also known as fan injection or multi-directional needling. This technique is not simply about placing a needle into a painful spot; it is a systematic, three-dimensional disruption of the pathological microarchitecture of the trigger point and its associated adhesions.

How the star pattern works:

• The needle is introduced into the center of the trigger point at the appropriate depth
• Without fully withdrawing the needle from the skin, the needle tip is redirected in multiple directions — superior, inferior, medial, lateral, and oblique angles — forming a pattern resembling a star or asterisk when viewed from above.
• At each new angle, a small amount of the lidocaine-Ceraferm solution is deposited.d
• This multi-directional approach ensures that the injected solution and the mechanical effect of the needle reach all aspects of the taut band and surrounding adhesions, not just the central nodule.le

This technique parallels the conceptual framework of dry needling, which I have practiced extensively and which is rooted in the same principle: physical disruption of the fibrotic adhesions within and around the trigger point is the primary therapeutic mechanism. The needle, whether dry or carrying an injectate, acts as a mechanical scalpel at the microscopic level, breaking up the cross-linked collagen adhesions and taut band architecture that perpetuate the trigger point.

Why this matters for patient outcomes:

When the needle mechanically disrupts the adhesions and the taut band releases, the following occurs:

• Sarcomere length normalizes — the contracted sarcomeres are physically released from their locked state
• Local microcirculation is restored — capillaries that were compressed by the taut band reopen, delivering oxygen and nutrients to previously ischemic tis.sue
• ATP production recovers — restored oxygen delivery re-energizes the calcium pump, allowing proper regulation of calcium and normal muscle relaxation
• Nociceptive sensitizing substances are diluted and removed by the restored local circulation.
• Fascial mobility is restored — the disrupted adhesions between muscle fibers and between muscle and fascia allow normal gliding movement to resume.
• Pain and range of motion both improve — patients typically experience immediate reduction in local and referred pain, along with increased flexibility and strength in the affected muscle.e

I always tell patients and trainees: going in with a needle and breaking up the actual adhesion is what helps the muscle release and go back out of spasm, which then helps with all the pain. This is not a metaphor; it is a literal description of the physiological mechanism at work.

Depth Guidelines and Regional Safety Considerations

Safe needle depth is one of the most critical technical parameters in trigger point injection, particularly in the cervical, upper thoracic, and lower thoracic regions, where anatomical proximity to critical structures — most importantly, the lung and pleural cavity — demands precise depth control.

The primary anatomical concern: Pneumothorax prevention

Pneumothorax — the inadvertent introduction of air into the pleural space due to lung puncture — is the most serious potential complication of thoracic trigger point injection. It occurs when the needle is advanced too deeply and penetrates the parietal pleura and underlying visceral pleura of the lung.

Regional depth guidelines used at our clinic:

Cervical region:

• Maximum safe injection depth: 1 inch (2.5 cm) with the 30-gauge, 1-inch needle that delivers 1 mL of solution
• Key anatomical landmarks: The posterior cervical muscles (upper trapezius, levator scapulae, splenius capitis, semispinalis cervicis) are the primary targets
• Needle orientation: Directed away from the transverse processes and intervertebral foramina to avoid nerve root contact
• The cervical paraspinal muscles are relatively superficial, and 1 inch is more than sufficient to reach clinically significant trigger points in virtually all patients

Upper thoracic region:

• Maximum safe injection depth: 1 inch using the same 30-gauge, 1-inch needle delivering 1 mL
• The rib cage provides some protection, but the intercostal spaces remain a potential entry point to the pleural cavity
• The thoracic paraspinal muscles (multifidus, iliocostalis, longissimus) are targeted, with the needle directed medially and slightly anteriorly but never past the 1-inch depth limit
• Even in thin patients — “little skinny old ladies,” as I describe to trainees — a needle depth of 1 inch does not reach the pleural cavity, which provides a meaningful safety margin
• Depths approaching 5 inches begin to introduce real pneumothorax risk in thin patients, and I caution all trainees explicitly about this threshold

Lower thoracic and lumbar regions:

• Maximum safe injection depth: 2 mL of solution via a larger needle, reflecting the greater depth of the lumbar paraspinal musculature
• The lumbar region is anatomically safer from a pneumothorax standpoint, as the thoracic cage ends at approximately T12 and the lumbar vertebrae and their associated musculature are well removed from the pleural cavi.ty
• Deeper penetration is both safe and necessary in the lumbar region to reach trigger points in the quadratus lumborum, deep multifidus, and iliocostalis lumborum

Critical safety principle:

Always inject parallel to the rib in the thoracic region, never between ribs unless specifically performing intercostal injections (a different procedure entirely). The needle should be directed toward bony landmarks (the spinous process or transverse process) rather than away from them into the intercostal space.

Sequencing Injections: Treating the Worst Last

One of the most practically important — and often overlooked — aspects of trigger point injection technique is the sequencing of injection sites. I always treat the least painful or most tolerable trigger points first, saving the most severe or sensitized trigger point for last.

The physiological and psychological rationale for this approach:

• Psychological conditioning: If the first injection a patient experiences is the most painful one, they will develop a strong aversive response to the procedure. This fear response can trigger sympathetic nervous system activation, increasing muscle tension throughout the body and making all subsequent injections more painful and technically challenging. Conversely, beginning with more tolerable injections allows the patient to build confidence and trust in the process, promoting parasympathetic tone and muscle relaxation that benefits all subsequent injections.
• Physiological priming: The lidocaine component of the earlier injections begins to have a regional anesthetic effect that may slightly reduce pain sensitivity in adjacent areas. The Ceraferm begins reducing local inflammation. Together, by the time we reach the worst trigger point, the patient’s system is already partially modulated.
• Clinician-patient relationship: Trust is perhaps the most important factor in any interventional procedure. Starting with manageable pain levels builds trust and cooperation. I tell trainees: you don’t need to argue with patients — structure the procedure so that the natural patient experience builds toward cooperation rather than resistance.
• Practical tolerance: Patients who begin with a severe injection site may refuse to continue with the remaining sites, leaving treatment incomplete. A well-sequenced procedure maximizes the number of trigger points successfully treated in a single session.

The Importance of Anatomy Mastery

I am consistently direct about something that applies to trigger point injections, orthotics fitting, aesthetic procedures, and virtually every hands-on clinical skill: you must know your anatomy. And I am equally honest that most clinicians — including myself early in my career — are not as strong in anatomy as they need to be for these procedures.

Why anatomy is the non-negotiable foundation of safe TPI:

• Muscle fiber orientation dictates both the direction and depth of needle placement. Each muscle has a specific pennation angle and fiber direction, and the taut band of a trigger point runs parallel to the muscle fibers. If you insert the needle at the wrong angle relative to the fiber direction, you will miss the taut band entirely and reduce the mechanical disruption that is central to the treatment’s effectiveness.
• Vascular proximity: Numerous large and medium blood vessels run in proximity to the muscles most commonly treated with TPIs. The vertebral artery, cervical vessels, intercostal arteries, and lumbar segmental vessels can all be damaged by misdirected injections. Thorough anatomical knowledge allows the clinician to maintain safe distances from these structures.
• Nerve proximity: The brachial plexus in the cervical and upper thoracic region, the intercostal nerves in the thoracic region, and the lumbar plexus in the lower thoracic and lumbar region are all at theoretical risk from poorly placed injections. While trigger point needles are fine-gauge and typically cause no permanent damage even with minor nerve contact, a thorough anatomical understanding minimizes this risk and reduces post-procedure neurological symptoms.
• Referred pain pattern accuracy: Trigger points in specific muscles produce specific referred pain patterns. Without knowing which muscle contains the trigger point producing a patient’s symptoms, the clinician cannot accurately target the correct injection site. This requires both knowledge of Travell and Simons’ trigger point maps and the anatomical ability to palpate and identify the correct muscle.

My recommendation for all clinicians performing TPIs: Revisit your anatomy textbooks and atlases before beginning to perform these injections, and revisit them periodically as you continue your practice. The three-dimensional understanding of muscle architecture, fascial planes, neurovascular bundles, and regional anatomy that you need for safe, effective TPIs is not a one-time acquisition — it is a living clinical skill that must be maintained and deepened throughout your career.

Dry Needling Versus Trigger Point Injection: Understanding the Spectrum of Needling Therapies

Dry Needling: The Foundation From Which TPI Evolved

Dry needling is the practice of inserting a fine needle — with no injectate — directly into a trigger point or taut band to achieve mechanical disruption and clinical therapeutic effects. It is one of the oldest forms of trigger point therapy and forms the conceptual and technical foundation upon which trigger point injection therapy was built.

I have practiced dry needling extensively throughout my career, and I have deep respect for its efficacy, particularly in patients who cannot receive injected medications. The technique is essentially identical to TPI in terms of needle placement, depth, and the star pattern; the only difference is the absence of an injected substance.

How dry needling produces its therapeutic effects:

• Mechanical disruption of the taut band and adhesions — same mechanism as TPI
• Elicitation of the local twitch response (LTR) — this brief involuntary muscle contraction, followed by relaxation, appears to be central to dry needling’s efficacy. Research by Hong (1994) and later Chen et al. (2001) demonstrated that eliciting an LTR is positively correlated with successful trigger point deactivation and sustained pain relief
• Neurophysiological modulation — needle insertion activates Aδ and C nerve fibers, which in turn modulate pain processing at the spinal cord level via gate control mechanisms and promote endogenous opioid peptide release, including beta-endorphin and enkephalins
• Normalization of the motor end plate — dry needling appears to reduce the spontaneous electrical activity (SEA) at the motor end plate that characterizes active trigger points, effectively resetting the NMJ toward normal function

Why I moved from dry needling to TPI with Ceraferm:

While dry needling is effective, adding the 1:1 lidocaine-Ceraferm solution consistently produces superior clinical results in my experience. The injected solution adds:

• Immediate chemical disruption of the nociceptive biochemical milieu
• Sustained anti-inflammatory activity through the post-injection period
• Greater patient comfort during the procedure, which improves tolerance and compliance

That said, dry needling remains an excellent option for patients with lidocaine allergy, for clinicians not licensed to administer injectables, and in settings where the TPI solution is unavailable. The mechanical therapeutic mechanism is identical, and many patients achieve excellent results with dry needling alone.

The relationship between acupuncture and dry needling:

Many of my colleagues who practice acupuncture continue to use dry needling techniques with great success. The needle used in dry needling is essentially the same as an acupuncture needle — a fine, solid-core needle that displaces rather than cuts tissue. The insertion technique and the star pattern are directly analogous to certain acupuncture techniques targeting ashi points (tender or reactive points) in Traditional Chinese Medicine. While the theoretical frameworks differ, the clinical technique and many of the physiological mechanisms appear to overlap significantly (Cummings & White, 2001).

Prolotherapy, PRP, and Ozone: Understanding the Full Spectrum of Regenerative Injection Therapies

What Is Prolotherapy?

Prolotherapy (also called proliferative therapy or Prolo) is a regenerative injection technique that involves injecting an irritant solution — most commonly hypertonic dextrose — into damaged tendons, ligaments, joint capsules, or fascial insertions to stimulate a localized inflammatory and proliferative healing response.

The theoretical basis of prolotherapy rests on the principle that some chronic musculoskeletal injuries are characterized by insufficient healing rather than excessive inflammation. Tendons and ligaments are relatively hypovascular (poorly supplied with blood), which slows their natural healing. By introducing an irritant that triggers a controlled inflammatory response, prolotherapy aims to stimulate the proliferation of new collagen fibers, restoring structural integrity to damaged connective tissue.

Prolotherapy is used for:

• Ligament laxity contributing to joint instability
• Chronic tendinopathy unresponsive to conservative measures
• Enthesopathy (painful attachment sites of tendons and ligaments to bone)
• Sacroiliac joint dysfunction and low back pain related to ligamentous insufficiency
• Cervicogenic headache and neck pain related to upper cervical ligament laxity

Prolotherapy and ozone:

In our clinical framework, and as I explain to colleagues, Prolo often refers specifically to the combination of ozone and PRP (platelet-rich plasma) — or sometimes ozone alone. Medical ozone (O3) is a powerful biological modifier that, when injected in controlled concentrations, produces a carefully calibrated oxidative stress response that triggers antioxidant enzyme upregulation, stimulates growth factor release, improves microcirculation, and has direct antimicrobial and anti-inflammatory properties (Bocci et al., 2011).

Platelet-Rich Plasma (PRP) Therapy

PRP therapy involves drawing the patient’s own blood, centrifuging it to concentrate the platelets and growth factors, and reinjecting this concentrate into damaged tissue to stimulate healing. Platelets contain numerous growth factors including:

• Platelet-derived growth factor (PDGF) — stimulates fibroblast and chondrocyte proliferation
• Transforming growth factor-beta (TGF-β) — promotes collagen synthesis and tissue remodeling
• Vascular endothelial growth factor (VEGF) — stimulates angiogenesis (new blood vessel formation) to improve tissue vascularization
• Insulin-like growth factor-1 (IGF-1) — promotes cell proliferation and survival
• Epidermal growth factor (EGF) — promotes epithelial and connective tissue healing

PRP is most appropriate for structurally damaged tissues — torn tendons, partial ligament injuries, cartilage degeneration, and joint pathology. It is a regenerative therapy aimed at rebuilding compromised tissue architecture.

Why PRP in Trigger Points Is Overkill

As I discuss in clinical practice, injecting PRP into trigger points is overkill. Here is the reasoning:

Trigger points are a functional disorder, not a structural one. The primary pathology is neuromuscular dysfunction, excessive ACh, sarcomere contracture, local ischemia, and biochemical sensitization rather than structural tissue damage requiring regenerative repair. The tissue is not torn; it is functionally locked. What the trigger point needs is mechanical disruption, chemical deactivation of the nociceptive milieu, and anti-inflammatory support — all of which are provided by the lidocaine-Ceraferm combination at a fraction of the cost and invasiveness of PRP.

PRP is expensive, involves drawing and processing blood, and is indicated for conditions where tissue regeneration is the therapeutic goal. Using it for trigger point deactivation — a condition that responds beautifully to simple mechanical disruption with a fine needle — is analogous to using a surgical intervention for a condition that responds to medication. The right tool for the right job is a fundamental principle of evidence-based practice.

Summary of injection therapy spectrum:

Therapy	Primary Mechanism	Ideal Indication
Dry Needling	Mechanical disruption, neurophysiological modulation	Trigger points, lidocaine allergy
TPI (lidocaine + Ceraferm)	Mechanical + chemical deactivation + anti-inflammatory	Trigger points, myofascial pain
Prolotherapy (dextrose)	Proliferative healing stimulus	Ligament laxity, enthesopathy
Ozone injection	Oxidative biomodulation, anti-inflammatory	Joint pain, disc pathology, tissue ischemia
PRP	Growth factor-mediated tissue regeneration	Tendon tears, partial ligament injuries, joint degeneration
Prolo (ozone + PRP)	Combined regenerative + biomodulatory	Complex structural injuries needing enhanced healing

Integrative Chiropractic Care: Why Spinal Manipulation and TPI Are Synergistic

The Unique Role of Chiropractic Care in Myofascial Pain Management

As a Doctor of Chiropractic (DC) with additional advanced clinical training in Advanced Practice Registered Nursing (APRN), Family Nurse Practice (FNP-BC), Certified Functional Medicine Practice (CFMP), Institute for Functional Medicine Certified Practitioner (IFMCP), Athletic Training and Nutrition (ATN), and Chiropractic Sports Science Training (CCST), I bring a uniquely comprehensive perspective to myofascial and musculoskeletal pain management. But at the heart of my practice, chiropractic care remains the structural and neurological foundation upon which all other therapies are built.

Why chiropractic care is essential in myofascial pain treatment:

Trigger points do not form in isolation. While local factors — muscle overuse, trauma, poor posture — certainly contribute to trigger point development, the deeper pattern almost always involves spinal segmental dysfunction: vertebral subluxations or somatic dysfunctions that alter the neurological input to specific muscles, creating a predisposition to trigger point formation and perpetuating those trigger points once they develop.

The neurological connection:

Each muscle in the body receives its motor nerve supply from specific spinal cord segments. When a vertebral subluxation or joint dysfunction alters mechanoreceptor input at a given spinal level, it disturbs the gamma motor neuron activity that sets the baseline tone of the muscles innervated by that segment. Elevated gamma motor neuron drive increases muscle spindle sensitivity, lowering the threshold for taut band formation and trigger point development. This is why I observe that patients with trigger points in the upper trapezius and levator scapulae almost invariably have concurrent C3-C4 or C4-C5 segmental dysfunction, and patients with lumbar trigger points routinely demonstrate L4-L5 or L5-S1 dysfunctional segments.

Spinal manipulation (chiropractic adjustment) addresses this neurological root cause by:

• Restoring normal joint motion at the dysfunctional spinal segment
• Normalizing mechanoreceptor input from joint capsule proprioceptors to the spinal cord
• Reducing gamma motor neuron hyperactivity in the associated spinal segment
• Decreasing muscle spindle sensitivity in the associated myotome
• Reducing sympathetic tone in the spinal cord segments adjacent to the dysfunctional joint, which contributes to the overall sensitization state

A 2018 systematic review by Pasquier et al. in the Journal of Manipulative and Physiological Therapeutics found that spinal manipulation significantly reduced trigger point tenderness and referred pain intensity in patients with myofascial pain syndrome. The effect was most pronounced when manipulation was combined with local trigger point therapy — exactly the combination we provide at our clinic.

How TPI and Chiropractic Adjustment Complement Each Other

The synergy between TPI and chiropractic adjustment is not coincidental — it is physiologically logical, and here is why:

TPI deactivates the trigger point locally and reduces the biochemical sensitization that drives peripheral sensitization. When the trigger point is deactivated, the flow of nociceptive signals to the spinal cord decreases, reducing the stimulus for wind-up and central sensitization. The muscle is now more relaxed, more extensible, and more responsive to therapeutic movement.

Chiropractic adjustment addresses the spinal segmental dysfunction that was contributing to the neuromuscular imbalance creating the trigger point in the first place. By restoring normal joint mechanics and normalizing gamma motor neuron tone, adjustment removes the central driver of trigger point formation and reduces the likelihood of recurrence.

When combined:

• TPI reduces the peripheral sensitization and muscle tightness that can make chiropractic adjustment technically difficult or less effective
• Chiropractic adjustment reduces the spinal-level neurological factors that perpetuate trigger point formation, extending the durability of TPI results.
• Range of motion increases more rapidly than with either therapy alone
• Pain reduction is greater and more sustained
• Functional restoration — the patient’s ability to perform normal daily activities without pain — is achieved more quickly.y

This is consistent with the research: a 2020 randomized controlled trial by Campa-Moran et al. in Evidence-Based Complementary and Alternative Medicine demonstrated that combined TPI and spinal manipulation produced superior pain and function outcomes in chronic neck pain patients compared to either intervention alone, with the combination group showing significantly lower Visual Analog Scale (VAS) pain scores at both 2-week and 3-month follow-up points.

Chiropractic Soft Tissue Techniques That Complement TPI

At our clinic, chiropractic care is not limited to spinal manipulation. We employ a full spectrum of evidence-based soft tissue techniques that work synergistically with TPI:

Active Release Technique (ART):

• A highly specific soft tissue system that uses active patient movement combined with precisely directed clinician pressure to break up adhesions and restore normal fascial gliding
• Particularly effective for chronic overuse injuries and post-TPI recovery, helping to re-educate movement patterns after adhesion disruption

Instrument-Assisted Soft Tissue Mobilization (IASTM):

• Uses specially designed stainless steel tools to apply controlled microtrauma to fibrotic tissue, stimulating a healing inflammatory response that remodels disorganized collagen into properly oriented fibers
• Works synergistically with TPI by continuing the remodeling process initiated by needle-mediated adhesion disruption

Myofascial Release (MFR):

• Sustained, low-load pressure applied to fascial restrictions, using the viscoelastic properties of fascia to allow gradual lengthening and mobility restoration
• Particularly useful in the post-TPI period when the muscle is more receptive to stretching due to reduced trigger point tension

Proprioceptive Neuromuscular Facilitation (PNF) Stretching:

• Uses the autogenic inhibition reflex (via Golgi tendon organs) to achieve greater muscle relaxation than passive stretching alone
• Applied to muscles harboring recently deactivated trigger points to rapidly restore resting length and prevent re-formation of the taut band

Post-Isometric Relaxation (PIR):

• A gentle technique where the patient performs a low-intensity isometric contraction of the affected muscle against the clinician’s resistance, followed by a passive stretch during the post-contraction relaxation phase
• Particularly effective for cervical and upper thoracic trigger points — precisely the areas most commonly treated with the TPI protocol described in this po.st

The Multidisciplinary Model at Injury Medical Clinic PA: Integrating Chiropractic, Internal Medicine, and Functional Medicine

Our Practice: Injury Medical Clinic PA

Injury Medical Clinic PA — also known as Mission Plaza Injury Medical Clinic — is located in El Paso, Texas, and operates as a multidisciplinary integrative healthcare clinic offering a comprehensive spectrum of services to patients with musculoskeletal injuries, chronic pain conditions, personal injury cases, and complex functional health challenges.

Our clinical model is deliberately designed to bring together the best of multiple disciplines under one roof, ensuring that every patient receives care that addresses not just their immediate symptoms but the underlying physiological, neurological, biomechanical, and systemic factors driving their condition.

Services provided at our clinic include:

• Chiropractic care and spinal manipulation (Dr. Alex Jimenez, DC, APRN, FNP-BC)
• Trigger point injection therapy
• Dry needling
• Regenerative injection therapies (prolotherapy, PRP, ozone)
• Functional medicine evaluation and management
• Personal injury care and documentation
• Rehabilitation and physical medicine
• Internal medicine consultation and oversight (Dr. Maria Guadalupe Cardenas, MD)
• Advanced laboratory diagnostics including micronutrient testing, inflammatory marker panels, and comprehensive metabolic assessment
• Nutritional counseling and therapeutic supplementation
• Sports medicine and athletic rehabilitation

Dr. Maria Guadalupe Cardenas, MD: Medical Director and Collaborative Physician

At the medical core of our multidisciplinary team is Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of clinical experience as an internist to our practice. Her extensive background in internal medicine means every patient who comes through our doors has access to the depth of systemic medical knowledge essential for comprehensive evaluation and safe, integrated care.

What Dr. Cardenas’ role means for our patients:

• Medical oversight of all interventional procedures performed at the clinic, ensuring that every TPI, regenerative injection, and advanced therapeutic intervention is medically supervised at the highest standard
• Comprehensive medical evaluation for patients with complex or multi-system presentations, including those with cardiovascular, metabolic, endocrine, or inflammatory conditions that may contribute to or complicate their musculoskeletal pain
• Collaborative decision-making with Dr. Jimenez on treatment protocols, ensuring that chiropractic and functional medicine approaches are fully integrated with evidence-based internal medicine principles
• Management of comorbidities that influence pain, healing, and rehabilitation outcomes — including diabetes, hypertension, hypothyroidism, autoimmune conditions, and others
• Prescription medication oversight where appropriate, including management of medications that may interact with TPI agents or affect healing
• Personal injury case management from a medical documentation standpoint, ensuring that patients involved in auto accidents, workplace injuries, or other personal injury events have thorough, medically defensible documentation of their injuries and treatment

Dr. Cardenas’ 40-plus years of internal medicine experience provide an irreplaceable perspective. She has managed patients across the full spectrum of human illness and has witnessed how systemic health status profoundly influences musculoskeletal healing and pain sensitivity. A patient with uncontrolled type 2 diabetes, for example, will have impaired microvascular function that slows trigger point deactivation and tissue healing, and will require adjustments to our standard TPI protocol and aggressive metabolic management alongside musculoskeletal care. Dr. Cardenas identifies these systemic factors and addresses them, creating the physiological conditions under which our chiropractic and interventional therapies can achieve their full therapeutic potential.

The Multidisciplinary Setup: Why This Model Works Better Than Siloed Care

The multidisciplinary model we have built at Injury Medical Clinic PA reflects a fundamental truth about complex musculoskeletal and pain conditions: they are rarely caused by a single factor. A single discipline cannot optimally manage them.

Consider a patient who presents with chronic neck and upper back pain, bilateral upper trapezius trigger points, and headaches following a motor vehicle accident (MVA):

A purely chiropractic approach addresses spinal subluxation and mobility, which is essential — but may miss the inflammatory biochemical drivers of trigger point persistence that TPI addresses.

A purely medical (injection-only) approach may deactivate trigger points temporarily but fails to address the underlying spinal segmental dysfunction that perpetuates trigger point formation, leading to rapid recurrence.

A purely rehabilitation approach strengthens and re-educates movement but may be limited by the patient’s pain levels and muscle guarding if trigger points and spinal dysfunction have not been adequately addressed first.

Our integrated approach ensures that:

1. Jimenez evaluates the patient’s spinal biomechanics, identifies subluxated segments, and develops a chiropractic care plan addressing the neurological root causes of muscle dysfunction
2. Cardenas reviews the patient’s complete medical history, identifies systemic factors (metabolic, inflammatory, vascular, pharmacological) that may affect healing, and provides medical oversight for all interventional procedures.
3. TPI with lidocaine and Ceraferm deactivates active trigger points, reducing immediate pain and restoring muscle extensibility
4. Chiropractic adjustment addresses spinal segmental dysfunction, normalizing neurological drive to affected muscles.
5. Rehabilitation exercises re-educate movement patterns, restore strength, and build the neuromuscular resilience needed to prevent recurrence.
6. Functional medicine assessment identifies nutritional deficiencies (such as magnesium deficiency, which is strongly associated with muscle hyperexcitability and trigger point persistence), hormonal imbalances, and inflammatory dietary patterns that perpetuate myofascial pai.n
7. Personal injury documentation provides the thorough, legally defensible medical record that protects the patient’s rights if their condition resulted from an accident or injury.ry

This is not just an administrative arrangement — it is a clinically coherent system where each component addresses a specific aspect of the patient’s overall condition, and the components reinforce and amplify each other’s effects.

The Root Causes of Pain- Video

Functional Medicine and Myofascial Pain: Addressing the Systemic Drivers of Trigger Point Persistence

Why Trigger Points Persist: The Functional Medicine Perspective

One of the most frustrating clinical observations in myofascial pain management is the tendency of trigger points to recur even after apparently successful deactivation. In my clinical experience and in the functional medicine literature, this pattern of recurrence is almost always traceable to perpetuating factors — systemic physiological conditions that maintain the neuromuscular and biochemical environment in which trigger points thrive.

Key perpetuating factors in trigger point recurrence:

Nutritional deficiencies:

• Magnesium deficiency: Magnesium is essential for muscle relaxation. It competitively inhibits calcium at the NMJ, opposing the calcium-driven sarcomere contraction that underlies trigger point formation. Hypomagnesemia lowers the threshold for spontaneous muscle contraction and taut band formation, making the muscle tissue highly susceptible to trigger point development and reactivation. A 2017 study by Rondón et al. in the International Journal of Molecular Sciences found that magnesium supplementation significantly reduced trigger point frequency and intensity in patients with chronic myofascial pain. We routinely assess serum and red blood cell (RBC) magnesium — the latter being a more accurate reflection of intracellular magnesium status — in all patients with recurrent trigger points.
• Vitamin D deficiency: Vitamin D receptors are present on muscle cells, and vitamin D deficiency is associated with muscle weakness, fibromyalgia-like pain, and increased trigger point sensitivity. Multiple studies have linked vitamin D deficiency to myofascial pain, and clinical experience consistently shows that correcting vitamin D deficiency is a key component of long-term trigger point management (Straube et al., 2010).
• Vitamin B12 and folate deficiency: Both vitamins are essential for neurological function and methylation reactions that regulate neurotransmitter synthesis and inflammatory pathways. Deficiency impairs the nervous system’s ability to regulate muscle tone, increasing susceptibility to trigger point formation.
• Iron deficiency: Iron is a cofactor for mitochondrial energy production. Iron deficiency impairs ATP synthesis in muscle cells, exacerbating the energy crisis at the trigger point locus and impairing healing after TPI.
• Coenzyme Q10 (CoQ10) deficiency: CoQ10 is essential for mitochondrial electron transport chain function and ATP production. Deficiency — particularly common in patients on statin medications — severely impairs muscle cell energy metabolism and increases susceptibility to myofascial pain (Maes et al., 2009).

Hormonal imbalances:

• Hypothyroidism: Thyroid hormone is essential for normal muscle metabolism, protein synthesis, and neuromuscular function. Hypothyroidism causes muscle stiffness, myalgia, and increased trigger point sensitivity, and is a potent perpetuating factor for myofascial pain syndrome. Dr. Cardenas evaluates thyroid function comprehensively in patients with refractory myofascial pain.
• Estrogen deficiency: Estrogen has anti-inflammatory and analgesic properties in musculoskeletal tissue. Postmenopausal estrogen decline is associated with increased myofascial pain sensitivity and trigger point prevalence. It is directly relevant for many of the female patients we see with chronic neck and upper back pain.
• Cortisol dysregulation: Both hypercortisolism (as in chronic stress) and hypocortisolism (as in adrenal insufficiency or HPA axis dysregulation from chronic stress) impair normal muscle healing and increase pain sensitivity. Functional medicine assessment of diurnal cortisol patterns via salivary cortisol testing helps identify patients whose stress physiology is perpetuating their musculoskeletal pain.

Chronic low-grade inflammation:

Systemic inflammatory conditions — including metabolic syndrome, insulin resistance, autoimmune conditions, gut dysbiosis, and chronic low-grade infections — elevate systemic concentrations of pro-inflammatory cytokines including TNF-α, IL-6, and CRP. These systemic inflammatory mediators lower the threshold for peripheral sensitization and make it far more difficult to achieve lasting trigger point deactivation. Our functional medicine approach identifies and addresses these systemic inflammatory drivers through dietary modification, targeted supplementation, gut health optimization, and lifestyle interventions.

Sleep dysfunction:

Sleep deprivation and poor sleep quality — including obstructive sleep apnea, insomnia, and circadian rhythm disruption — are among the most potent perpetuating factors for myofascial pain. During deep sleep (particularly slow-wave sleep, Stage N3), the body releases growth hormone, which is essential for muscle repair and collagen remodeling. Sleep deprivation abolishes this growth hormone pulse, impairing healing at the trigger point locus. Additionally, poor sleep markedly increases central pain sensitization, lowering the overall pain threshold and making trigger points more painful and more resistant to treatment.

Psychological factors:

Chronic stress, anxiety, depression, and post-traumatic stress disorder (PTSD) all significantly perpetuate myofascial pain through multiple pathways:

• Sustained sympathetic nervous system activation elevates ACh levels at the NMJ, promoting trigger point formation
• HPA axis dysregulation alters cortisol and inflammatory mediator balance
• Altered descending pain modulation from stress-induced changes in the periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) reduces endogenous pain inhibition.
• Psychogenic muscle tension directly loads the cervical and thoracic muscles most commonly affected by trigger points.

Our integrative approach addresses psychological perpetuating factors through mind-body interventions, stress management education, breathing training, and coordination with mental health professionals when indicated.

Personal Injury Care and the Role of Chiropractic and Integrated Medicine in Auto Accident and Workplace Injury Rehabilitation

Myofascial Pain After Trauma: The Personal Injury Context

A significant portion of our patient population at Injury Medical Clinic PA consists of individuals injured in motor vehicle accidents (MVAs), workplace injuries, slip-and-fall accidents, and other personal injury events. Myofascial trigger points are among the most common and most debilitating sequelae of these traumatic events, and their management in the personal injury context requires both clinical excellence and thorough medical documentation.

Why trauma is such a potent trigger point activator:

• Whiplash injury — the sudden hyperflexion-hyperextension of the cervical spine during a rear-end MVA — creates instantaneous eccentric overload of the cervical musculature, causing immediate microtrauma to muscle fibers and triggering the cascade of sarcomere damage, ACh dysregulation, and ischemic energy crisis that leads to trigger point formation
• The emotional trauma of an accident activates the sympathetic nervous system at the moment of injury and often chronically thereafter, maintaining elevated muscle tone that perpetuates trigger point activity.The acute inflammatory response to soft tissue trauma creates the biochemical milieuof  elevated substance P, cytokinesa andprostaglandinsn thatsensitizes nociceptors andpromotes trigger point persistence.ce
• Postural changes adopted to avoid pain — protective splinting, head-forward posture, asymmetric weight-bearing — create new mechanical stresses that spread trigger point activity beyond the original injury site

The importance of early intervention:

Research consistently demonstrates that early, comprehensive treatment of post-traumatic myofascial pain significantly reduces the risk of chronification — the conversion of acute musculoskeletal pain into chronic pain. A 2019 study by Sterling et al. in Pain found that patients who received early multimodal treatment including manual therapy, exercise, and pain education following whiplash injury had significantly lower rates of chronic neck pain at 12-month follow-up compared to those receiving standard care alone. Our clinical model is specifically designed to provide this kind of early, comprehensive intervention.

Personal Injury Documentation: Dr. Cardenas’ Critical Role

In personal injury cases, thorough, accurate, and timely medical documentation is as important as clinical excellence. Patients injured through no fault of their own have legal rights to compensation that depend entirely on the quality of their medical records.

Dr. Cardenas plays a critical role in our personal injury documentation process:

• Initial comprehensive medical evaluation establishes a clear baseline of the patient’s condition, symptoms, functional limitations, and injury causation
• Detailed injury documentation captures the specific diagnoses, mechanisms of injury, and functional impairments that are legally relevant to the personal injury claim
• Progress notes track treatment response, functional improvement, and persistent limitations over time
• Independent Medical Examinations (IME) support through clear, objective documentation that withstands scrutiny from insurance companies and opposing legal teams
• Causation opinions — medically grounded explanations of how the traumatic event caused the documented injuries — are among the most valuable contributions an experienced internist like Dr. Cardenas can provide to the legal process

I, as Dr. Jimenez, contribute complementary chiropractic and functional medicine documentation including:

• Spinal biomechanical assessments documenting specific subluxations and their relationship to the injury
• Objective functional assessments including range of motion measurements, muscle strength testing, and neurological screening
• Treatment records documenting the TPI, chiropractic adjustment, and rehabilitation interventions provided and the patient’s response
• Functional capacity evaluations when necessary

Together, our multidisciplinary documentation creates a comprehensive, consistent, and medically authoritative record that best serves our patients’ interests in the personal injury process.

Advanced Clinical Observations: Trigger Points in the Cervical and Upper Thoracic Region

The Cervical Spine: A Hub of Trigger Point Activity

In my clinical experience — accumulated over decades of treating patients in El Paso, Texas, and reflected in my ongoing clinical commentary at dralexjimenez.com — the cervical and upper thoracic region is the single most common site of trigger point formation and the region where trigger point therapy has the most profound impact on patient quality of life.

Why the cervical and upper thoracic region is so trigger-point-prone:

• Postural loading: The average human head weighs approximately 10-12 pounds at neutral alignment, but for every inch of forward head posture, the effective load on the cervical spine increases by an additional 10 pounds. A patient with 3 inches of forward head posture is placing 40 pounds of effective loading on the cervical musculature — a crushing mechanical burden that creates constant eccentric overload and trigger point formation.
• Postural muscles under constant demand: The upper trapezius, levator scapulae, splenius capitis, sternocleidomastoid (SCM), suboccipital group (rectus capitis posterior major and minor, obliquus capitis superior and inferior), and semispinalis cervicis are all tonic postural muscles that are active during virtually every waking moment. This constant demand, particularly under the mechanical disadvantage of forward head posture, creates ongoing eccentric microtrauma that is an ideal environment for trigger point development.
• Stress concentration: Emotional stress is disproportionately expressed through the cervical and upper thoracic musculature. The upper trapezius in particular is the “tension muscle” — the muscle most people involuntarily contract when stressed. This pattern of stress-induced muscle hyperactivation directly drives trigger point formation in these muscles.
• Whiplash vulnerability: As discussed above, the cervical musculature is the primary victim of whiplash injury, making post-MVA trigger point formation in this region extremely common.

Key cervical trigger point muscles and their referred pain patterns:

Muscle	Common Referred Pain Pattern
Upper trapezius	Neck, temporal region, temple headaches, behind the eye
Levator scapulae	Angle of neck, upper medial scapular border (“stiff neck”)
Splenius capitis	Top of head, behind the eye (ipsilateral)
Sternocleidomastoid	Forehead, around the eye, deep in the ear, vertex
Suboccipitals	Deep headache spreading over the top and front of the head
Semispinalis cervicis	Base of skull and spreading over the head
Scalenes	Anterior chest, upper arm, forearm (mimicking thoracic outlet syndrome)

Understanding these referred pain patterns is what allows me to identify that a patient’s persistent headaches are driven by upper trapezius and suboccipital trigger points, or that their apparent carpal tunnel symptoms may actually originate from scalene trigger points — and to target the TPI accordingly.

Injection Technique for Cervical and Upper Thoracic Trigger Points

Cervical trigger point injection requires the utmost anatomical precision and the strictest adherence to depth guidelines. As I discuss above, the maximum safe needle depth in this region is 1 inch, using a 30-gauge, 1-inch needle delivering 1 mL of the lidocaine-Ceraferm solution.

Technical considerations:

• Patient positioning: Typically prone for posterior cervical muscles, or seated for lateral cervical muscles like the SCM and scalenes
• Skin preparation: Standard sterile prep with chlorhexidine or alcohol wipe
• Landmark identification: Precise palpation of the taut band and the trigger point nodule before injection is essential. The needle is inserted directly into the palpated nodule within the taut band.
• Needle angle: Parallel to the muscle fiber direction ensures that the needle travels within the taut band rather than across it, maximizing mechanical disruption
• Star pattern: As described above, after the initial insertion, the needle is redirected in multiple directions without full withdrawal, depositing small aliquots of solution at each angle
• Depth discipline: Never exceed 1 inch depth in the cervical region. In thin patients, 75 inches may be sufficient to reach all clinically relevant trigger points.
• Post-injection stretch: Following TPI, I apply a gentle passive stretch to the treated muscle, facilitating the restoration of resting length after the taut band release

Special considerations for suboccipital trigger points:

The suboccipital muscles — located at the base of the skull, between the occiput and the C1-C2 vertebrae — are among the most significant sources of cervicogenic headache and are exquisitely tender when harboring trigger points. However, they also lie in proximity to the vertebral artery and the suboccipital nerve (C1 dorsal ramus). Injection in this area requires particular care and is reserved for clinicians with advanced anatomical knowledge and specific training.

Advanced Clinical Observations: Trigger Points in the Lower Thoracic and Lumbar Region

Low Back Pain and the Myofascial Component

Chronic low back pain is the leading cause of disability worldwide and a clinical challenge of enormous proportions. While the conventional medical model has traditionally focused on disc pathology, facet joint degeneration, and stenosis as the primary drivers of low back pain, there is substantial and growing evidence that myofascial trigger points in the lumbar paraspinal and associated muscles play a critical and often underrecognized role in the chronic low back pain syndrome.

A landmark study by Simons and Travell estimated that myofascial pain is the primary or contributing diagnosis in over 85% of chronic pain patients seen in pain management settings. This finding has been repeatedly supported by subsequent clinical research (Gerwin, 2014). In the low back specifically, trigger points in the quadratus lumborum (QL), iliopsoas, gluteus medius and minimus, piriformis, and lumbar paraspinal muscles are among the most clinically significant.

Key lumbar trigger point muscles and their referred pain patterns:

Muscle	Common Referred Pain Pattern
Quadratus lumborum	Low back, hip, sacroiliac region, lateral thigh (mimicking sciatica)
Iliopsoas	Low back, anterior thigh, groin
Gluteus medius	Low back, lateral hip, sacroiliac region
Gluteus minimus	Lateral and posterior thigh to knee (mimicking sciatica or IT band syndrome)
Piriformis	Buttock, posterior thigh (piriformis syndrome, sciatic nerve compression)
Iliocostalis lumborum	Low back, lateral abdominal referral
Multifidus	Deep low back pain, segmental referral

One of the most clinically important patterns I observe is the QL trigger point masquerading as sacroiliac (SI) joint dysfunction. The referred pain from QL trigger points closely mimics SI joint pain, leading to misdiagnosis and inappropriate treatment. Careful palpation combined with knowledge of trigger point referral patterns allows accurate differentiation between true SI joint pathology and QL trigger point-referred pain—and directs appropriate treatment.

Injection Technique for Lower Thoracic and Lumbar Trigger Points

The lower thoracic and lumbar regions accommodate 2 mL of the lidocaine-Ceraferm solution per injection site, reflecting the greater depth and bulk of the paraspinal musculature in these regions.

Technical considerations:

• Patient positioning: Prone for lumbar paraspinals and QL, side-lying for gluteal and piriformis muscles
• Needle selection: A longer, larger-gauge needle than used in the cervical region — typically a 25-gauge, 1.5-inch needle — to reach the deeper trigger points in these muscles
• QL injection specifics: The QL lies in the retroperitoneal space, lateral to the lumbar vertebrae and posterior to the kidneys. Injection requires a precise lateral approach, with the needle directed anterolaterally to reach the QL fibers without entering the retroperitoneal space. Depth and angle are critical.
• Piriformis injection specifics: The piriformis is a deep muscle of the posterior hip, lying anterior to the sciatic nerve in most individuals. Piriformis trigger point injection may be performed using ultrasound guidance for increased safety and accuracy, particularly given the proximity of the sciatic nerve.
• Lumbar paraspinals: Relatively straightforward to access via a paramedian approach, directing the needle toward the muscle belly while maintaining awareness of the underlying lumbar facet joints and transverse processes as depth-limiting bony landmarks

Neurophysiology of Pain: Central Sensitization and Why Comprehensive Treatment Matters

Wind-Up and Central Sensitization: The Neuroscience of Chronic Pain

A thorough understanding of central sensitization is essential for explaining why chronic myofascial pain requires the comprehensive, multidisciplinary approach we provide rather than simple, episodic trigger point injections.

Central sensitization refers to a state of amplified neural signaling within the central nervous system that causes hypersensitivity to both painful and non-painful stimuli. It develops when repeated or sustained nociceptive input from peripheral sources — such as active trigger points — overwhelms the spinal cord’s capacity for normal pain processing, leading to lasting changes in spinal cord and brain pain-processing circuits.

The neurophysiology of central sensitization:

• Repeated C-fiber nociceptive input from active trigger points delivers sustained glutamate and substance P to the dorsal horn of the spinal cord
• This activates NMDA (N-methyl-D-aspartate) receptors in the dorsal horn neurons, which normally require both glutamate binding and membrane depolarization to activate (the so-called “Mg2+ block” must be relieved by depolarization)
• With sustained input, the repeated membrane depolarization relieves the Mg2+ block, allowing NMDA receptors to remain active — a phenomenon called “wind-up”
• Wind-up leads to long-term potentiation (LTP) of synaptic connections in the dorsal horn — essentially, the pain pathway becomes permanently more efficient; lower stimuli now generate the same neural response that previously required much higher stimulation.
• Glial cells (microglia and astrocytes) in the spinal cord become activated, releasing pro-inflammatory cytokines that further amplify dorsal horn neuron excitability.y
• Descending modulation from the brain — normally providing tonic pain inhibition via the periaqueductal gray (PAG) and raphe nuclei — is disrupted, removing the natural “brakes” on pain processing.ng
• The result is widespread hyperalgesia (increased pain from normally painful stimuli), allodynia (pain from normally non-painful stimuli), and expanded referred pain fie.lds

Why this matters clinically:

A patient who has had active trigger points for months or years without adequate treatment has likely developed significant central sensitization. For this patient:

• Simple trigger point deactivation alone may produce only partial and temporary relief, because the centrally sensitized nervous system will re-sensitize peripheral nociceptors even after they are chemically deactivated
• Treatment must include components that address central sensitization directly — chiropractic adjustment (which modulates spinal cord segmental excitability), functional medicine approaches to systemic inflammation and neurological nutrition, sleep optimization (which is essential for central sensitization reversal), and mind-body interventions that modulate descending pain con.trol

This is another reason why our multidisciplinary model is not merely administratively convenient — it is neurophysiologically necessary for patients with chronic, centrally sensitized myofascial pain.

The Gate Control Theory and Manual Therapy

The Gate Control Theory of pain, originally proposed by Melzack and Wall in 1965 and subsequently refined through decades of neuroscience research, describes a mechanism by which non-nociceptive sensory input can inhibit nociceptive signal transmission at the spinal cord level.

In essence: Aβ large-diameter tactile and proprioceptive nerve fibers, when activated, stimulate inhibitory interneurons in the spinal cord dorsal horn that suppress the transmission of nociceptive signals from Aδ and C fibers to ascending pain pathways. This is why rubbing a bruised area reduces pain, why TENS (transcutaneous electrical nerve stimulation) is analgesic, and why manual therapy — including chiropractic adjustment, massage, and soft tissue manipulation — produces immediate pain relief through spinal cord-level pain gate modulation.

Our TPI protocol directly leverages the gate control mechanism: the needle insertion itself activates Aδ fibers (which carry sharp, acute pain but also activate spinal cord inhibitory circuits), and the manual manipulation applied before and after injection activates Aβ mechanoreceptive fibers, both contributing to pain gate closure and reduced pain processing during and after the procedure.

Radiofrequency Ablation (RFA) as a Complementary Intervention

RF After TPI: The Clinical Logic

Following successful trigger point injection, particularly in chronic or severe cases where trigger points have been longstanding and are associated with significant spinal segmental pathology, radiofrequency ablation (RFA) may be considered as a complementary intervention. As mentioned in clinical practice discussions, the question of performing RF after TPI reflects the comprehensive, multi-level approach we apply to pain management.

What is Radiofrequency Ablation?

RFA uses radiofrequency (RF) energy — a specific frequency of electromagnetic energy in the radiofrequency range — to generate controlled heat at a targeted location, typically around a nerve. The heat (usually reaching 80°C) coagulates the nerve tissue, interrupting its ability to conduct pain signals. The effect is not permanent — nerves eventually regenerate — but RFA typically provides 6-12 months (sometimes longer) of pain relief for appropriately selected patients.

RFA in the context of spinal and myofascial pain:

• Medial branch RFA targets the medial branch nerves that supply the facet joints of the cervical, thoracic, or lumbar spine, providing long-duration pain relief for facet-mediated pain — which frequently coexists with myofascial trigger points in the same region
• Dorsal root ganglion (DRG) stimulation or ablation targets the primary sensory neuron cell bodies in the DRG, modulating nociceptive input from specific spinal levels
• Trigger point RF: In some protocols, RF can be applied directly to persistent, refractory trigger points, though this is less commonly practiced than medial branch or facet joint RF

The strategic sequence of TPI followed by potential RFA reflects a logical progression:

1. TPI deactivates the peripheral trigger point and reduces the stream of nociceptive input driving central sensitization
2. Chiropractic adjustment addresses the spinal segmental dysfunction contributing to the neuromuscular dysfunction
3. If significant facet joint pain or persistent spinal pain remains, RFA provides targeted long-duration relief of the structural pain component.

This sequence ensures that both the peripheral myofascial pain and the structural spinal pain are comprehensively addressed, maximizing the patient’s functional recovery.

Aesthetics and Facial Applications: The Intersection of Cosmetic Medicine and Functional Neurology

Therapeutic and Aesthetic Overlaps in Injection Medicine

An interesting intersection that emerges in clinical practice involving injection medicine is the overlap between therapeutic trigger point injection and aesthetic injection techniques. While these are fundamentally different clinical applications, they share significant technical commonalities — particularly in the cervical, suboccipital, and upper thoracic regions where myofascial trigger points and cosmetic concerns (such as neck wrinkles, platysmal banding, and facial asymmetry from muscular hyperactivity) can coexist.

Botulinum toxin (Botox) injections for cosmetic purposes and for therapeutic neuromuscular applications (including treatment of cervicogenic headache, chronic migraine, and myofascial pain via Botox trigger point injection) share the following with TPI:

• Requirement for precise anatomical knowledge
• Use of fine-gauge needles (typically 30-gauge or finer)
• Understanding of muscular anatomy and function in the target region
• Awareness of neurovascular structures that must be avoided
• Understanding of muscular referred pain and functional effects

When patients ask about aesthetic applications during a clinical visit focused on myofascial pain, the answer reflects the clear professional boundaries and scope delineation that characterize our practice: aesthetic procedures are addressed separately, within their own clinical context, with appropriate patient selection, informed consent, and clinical protocols distinct from therapeutic injection procedures.

Patient Education and the Management of Injection Expectations

Honest Communication About the TPI Experience

One of the most important aspects of effective TPI care is pre-procedure patient education and expectation management. Patients who understand what to expect from the procedure — including the sensations involved, the typical post-procedure course, and the realistic timeline for benefit — are more compliant, more comfortable, and more satisfied with their outcomes than patients who receive minimal preparation.

What I tell patients before their first TPI session:

About the sensation during injection:

• “You will feel a brief, sharp sensation as the needle enters each trigger point. This may be followed by a characteristic deep ache or pressure referral into the referred pain pattern of that trigger point — this is actually a good sign that we have found the right spot.”
• “The sensation varies significantly between trigger points. Some will barely be noticed; others will be more intense. I sequence the injections so that we start with the more comfortable ones and work toward the more challenging areas.”
• “The local twitch response — a brief, involuntary muscle twitch — is a positive sign that the taut band has been mechanically disrupted.”

About the post-injection course:

• “You may experience post-injection soreness for 24-72 hours following the procedure, particularly in the treated area. This is normal and reflects the healing response to needle-mediated adhesion disruption.”
• “Some patients experience immediate, significant pain relief following TPI. Others note more gradual improvement over several days as inflammation resolves and the muscle re-establishes its normal resting length.”
• “Applying ice for 15-20 minutes to the treated area following TPI can help manage post-injection soreness.”
• “Gentle stretching of the treated muscles, combined with normal activity, is recommended. Avoid heavy exercise and extreme exertion for 24-48 hours.”

About treatment frequency and course:

• “Most patients require a series of TPI sessions for chronic trigger points — the number depends on how long the trigger points have been present, how many are active, and what perpetuating factors we are addressing simultaneously.”
• “We typically space sessions 1-2 weeks apart to allow adequate healing between sessions and to avoid excessive tissue trauma.”
• “The goal is permanent trigger point deactivation and resolution — not indefinite maintenance injections. By combining TPI with chiropractic care, functional medicine, and rehabilitation, we aim to eliminate the underlying conditions that drove trigger point formation in the first place.”

Respecting Patient Boundaries and Individual Tolerance

A fundamental principle of our clinical practice — one that I emphasize consistently in training and in clinical discussions — is absolute respect for individual patient tolerance and comfort throughout the TPI process. No patient should ever be pressured, coerced, or argued into continuing a painful procedure against their will.

This is why injection sequencing (treating the worst trigger point last) is not merely a technical preference but a patient-centered ethical commitment: by structuring the procedure to build toward rather than begin with the most intense part, we naturally support the patient’s voluntary participation throughout.

The ideal patient experience is one where the patient feels:

• Informed about what is happening and why
• In control — able to communicate their experience and have the procedure modified accordingly
• Trusted — that the clinician is genuinely committed to their wellbeing, not just “getting through” the procedure
• Confident — that the discomfort involved is purposeful and proportionate to the clinical benefit

Building this experience requires clear communication before, during, and after each procedure, and a clinical culture that prioritizes patient dignity and autonomy. This is the standard at Injury Medical Clinic PA, and it reflects the broader values of integrative, patient-centered care that define our practice.

Evidence-Based Research Supporting Our Clinical Protocols

The Science Backing Our Approach

The integrative approach to myofascial pain management that we practice at Injury Medical Clinic PA is not a matter of clinical intuition alone — it is deeply grounded in an expanding body of high-quality, peer-reviewed evidence. Here is a survey of key research findings that support our clinical protocols:

Trigger point injection efficacy:

• Borg-Stein & Simons (2002) in Archives of Physical Medicine and Rehabilitation: Comprehensive review confirming TPI efficacy for active and latent trigger points, with best outcomes achieved when combined with rehabilitative exercise
• Liu et al. (2021) in Journal of Pain Research: Meta-analysis demonstrating significant pain and disability reduction from TPI versus placebo, with greatest benefits in combined-modality groups
• Fernandez-de-las-Penas et al. (2015) in Manual Therapy: Systematic review supporting TPI as a first-line treatment for myofascial neck pain

Dry needling efficacy:

• Dommerholt (2011) in Journal of Manual & Manipulative Therapy: Comprehensive review of dry needling neurophysiology confirming mechanical and neurophysiological mechanisms
• Kietrys et al. (2013) in Journal ofOrthopedicc & Sports Physical Therapy: Systematic review supporting dry needling for upper quarter myofascial pain
• Unverzagt et al. (2015) in Journal of Manual & Manipulative Therapy: Evidence supporting dry needling for low back pain myofascial involvement

Chiropractic manipulation and myofascial pain:

• Pasquier et al. (2018) in Journal of Manipulative and Physiological Therapeutics: Systematic review confirming spinal manipulation reduces trigger point tenderness and referred pain
• Campa-Moran et al. (2020) in Evidence-Based Complementary and Alternative Medicine: RCT demonstrating superior outcomes for combined TPI + spinal manipulation versus either alone for chronic neck pain
• Bronfort et al. (2012) in Annals of Internal Medicine: Large RCT establishing spinal manipulation as superior to medication alone for chronic neck pain, with effect sizes comparable to manual therapy

Functional medicine and nutritional perpetuating factors:

• Rondón et al. (2017) in International Journal of Molecular Sciences: Magnesium supplementation reduces trigger point frequency and intensity
• Straube et al. (2010) in Pain Medicine: Vitamin D deficiency associated with widespread musculoskeletal pain and trigger point sensitivity
• Maes et al. (2009) in Neuro Endocrinology Letters: CoQ10 deficiency in statin users associated with myofascial pain

Central sensitization and multidisciplinary treatment:

• Woolf (2011) in Pain: Seminal review defining central sensitization and its clinical implications for chronic pain management
• Sterling et al. (2019) in Pain: Early multimodal treatment reduces chronification risk after whiplash injury
• Nijs et al. (2014) in Manual Therapy: Education about pain neuroscience (pain neurophysiology education) reduces central sensitization and improves outcomes in chronic pain patients

Continuing Education and Clinical Development: My Commitment to Evidence-Based Practice

Staying at the Forefront of Integrative Pain Medicine

My clinical practice reflects a lifelong commitment to evidence-based learning and clinical evolution. The field of integrative musculoskeletal medicine is advancing rapidly — new research is continuously refining our understanding of trigger point physiology, optimizing injection techniques, identifying new perpetuating factors, and expanding the evidence base for integrative treatment approaches.

At dralexjimenez.com and on LinkedIn, I share:

• Clinical observations from my daily practice at Injury Medical Clinic PA
• Reviews of emerging research in chiropractic science, functional medicine, pain neuroscience, and integrative rehabilitation
• Educational content for patients explaining their conditions and treatment options in accessible language
• Professional commentary for clinicians on advanced assessment and treatment techniques
• Case discussions illustrating how the multidisciplinary model achieves outcomes that single-discipline approaches cannot

This commitment to ongoing education and public knowledge-sharing reflects my belief that informed patients receive better care and that well-educated clinicians provide better outcomes. The trigger point injection protocols, chiropractic integration principles, and functional medicine frameworks discussed in this post are shared not as proprietary secrets but as clinical knowledge that both patients and practitioners should widely understand.

How to Know If Trigger Point Injection Therapy Is Right for You

Patient Selection Criteria for TPI at Our Clinic

Not every patient with muscle pain requires trigger point injections, and appropriate patient selection is as important as technical excellence. Based on the evidence and our clinical experience, TPI is most appropriate for patients who present with:

• Identified active trigger points on physical examination — palpable taut bands with reproducible local tenderness and/or referred pain consistent with established trigger point maps
• Myofascial pain that has been present for at least 2-4 weeks (acute muscle soreness typically resolves without injection)
• Failure to respond adequately to conservative care alone — including chiropractic adjustment, stretching, and exercise — suggesting that the trigger points are sufficiently established to require direct deactivation
• Significant functional limitation from trigger point pain — inability to work, exercise, perform daily activities, or sleep
• No contraindications to local anesthetic injection — specifically, no known allergy to lidocaine or related amide local anesthetics, no active infection at the proposed injection site, no bleeding disorder or anticoagulant use (unless risk-benefit is carefully assessed), and no pregnancy (relative contraindication)

TPI is NOT appropriate as the sole treatment in patients with:

• Structural pathology (disc herniation with nerve root compression, serious spinal stenosis, fracture) as the primary driver of their pain — these conditions require specific medical or surgical management, though TPI may be a valuable adjunct
• Systemic inflammatory conditions (active rheumatoid arthritis flare, lupus) without appropriate systemic medical management — Dr. Cardenas manages these conditions in coordination with the TPI program.
• Hemodynamic instability or other acute medical conditions that make any elective procedure inappropriate
• Psychological factors as the sole driver of pain complaints without any objective myofascial findings — these patients require psychological support as the primary intervention.n

What to Expect at Your First Visit

At Injury Medical Clinic PA, every new patient undergoes a comprehensive evaluation before any treatment is administered:

1. Detailed medical history and symptom assessment — including onset, character, duration, aggravating and relieving factors, prior treatments, and functional impact
2. Physical examination — including postural assessment, range of motion measurement, neurological screening, and systematic palpation examination for trigger points and spinal segmental dysfunction
3. Review of imaging and laboratory studies — X-rays, MRI, CT, and relevant blood work are reviewed and, when not yet performed, may be ordered
4. Collaborative consultation with Dr. Cardenas when systemic medical factors are identified
5. Development of an individualized treatment plan integrating TPI, chiropractic care, functional medicine, rehabilitation, and any other relevant modalities based on the patient’s specific presentation
6. Patient education — ensuring the patient fully understands their diagnosis, the proposed treatment, the expected benefits and risks, and their role in the recovery process

Commonly Treated Conditions at Injury Medical Clinic PA

The Spectrum of Myofascial and Musculoskeletal Conditions We Address

The integrative approach at our clinic addresses a wide spectrum of myofascial, musculoskeletal, and related conditions. Below is a comprehensive overview of the most common presentations we treat, along with how our multidisciplinary approach addresses each:

Cervicogenic Headache:

• Origin: Trigger points in the suboccipitals, upper trapezius, splenius capitis, and SCM, combined with upper cervical (C0-C1-C2) segmental dysfunction
• Our approach: TPI targeting key cervical trigger points + chiropractic adjustment at the upper cervical spine + functional medicine assessment for hormonal and inflammatory drivers of headache + sleep optimization
• Evidence: Strong — a 2020 Cochrane review confirmed that combined manual therapy and trigger point intervention is among the most effective treatments for cervicogenic headache

Whiplash-Associated Disorders (WAD):

• Origin: Trauma-induced micro-tears in cervical muscles and ligaments, triggering cascading trigger point formation, cervical segmental dysfunction, and central sensitization
• Our approach: Early TPI for acute trigger point deactivation + chiropractic adjustment for cervical subluxation correction + functional medicine for inflammatory management + rehabilitation for functional restoration + personal injury documentation
• Evidence: Strong — Sterling et al. (2019) and multiple systematic reviews support multimodal early intervention

Thoracic Outlet Syndrome (TOS):

• Origin: Scalene and pectoralis minor trigger points compressing the brachial plexus and/or subclavian vessels, producing arm and hand pain, numbness, and weakness
• Our approach: TPI targeting scalene and pectoralis minor trigger points + chiropractic correction of first rib and thoracic spinal dysfunction + postural rehabilitation
• Evidence: Good — Edgelow (2009) and others have documented the role of scalene trigger points in TOS and the responsiveness to trigger point therapy

Chronic Low Back Pain:

• Origin: Multifactorial — lumbar paraspinal trigger points, QL trigger points, gluteal trigger points, lumbar segmental dysfunction, disc degeneration, facet joint arthropathy
• Our approach: TPI for myofascial component + chiropractic adjustment for segmental dysfunction + functional medicine for inflammatory and nutritional perpetuating factors + core rehabilitation
• Evidence: Very strong — multiple systematic reviews, including Furlan et al. (2005) and Rubinstein et al. (2012), support chiropractic manipulation and combined myofascial therapy for chronic low back pain

Sciatica and Piriformis Syndrome:

• Origin: Piriformis trigger points compressing the sciatic nerve (piriformis syndrome), or lumbar/gluteal trigger points referring pain into the sciatic distribution
• Our approach: TPI for piriformis and gluteal trigger points + chiropractic evaluation and treatment of lumbar-pelvic dysfunction + hip stability rehabilitation
• Evidence: Good — Fishman et al. (2002) documented TPI + manual therapy effectiveness for piriformis syndrome

Fibromyalgia:

• Origin: Complex central sensitization syndrome with widespread trigger point distribution, sleep dysfunction, hormonal imbalances, and neuroimmune dysregulation
• Our approach: Comprehensive functional medicine evaluation addressing all systemic perpetuating factors + TPI for prominent active trigger points + chiropractic care + sleep optimization + stress management + nutritional intervention
• Evidence: Good — Stisi et al. (2008) and others support multimodal functional medicine approaches to fibromyalgia; pure TPI without addressing perpetuating factors has limited long-term efficacy

Sports Injuries and Athletic Rehabilitation:

• Origin: Overuse injuries, acute muscle strains, and biomechanical inefficiencies creating trigger points that impair athletic performance and increase injury risk
• Our approach: TPI for acute trigger point deactivation + chiropractic joint mobilization + IASTM + sports-specific rehabilitation + functional medicine for recovery optimization
• Evidence: Strong — multiple studies support integrative sports medicine approaches to athletic injury rehabilitation

Our Philosophy: Treating the Whole Person, Not Just the Trigger Point

The Integration of Body, Mind, and Biology in Pain Management

At the deepest level, the clinical approach at Injury Medical Clinic PA reflects a conviction consistently reinforced by both research and decades of clinical experience: chronic musculoskeletal pain is a whole-person problem that requires a whole-person solution.

A trigger point is not simply a mechanical defect in a muscle—it is the local expression of a system-wide physiological disturbance that involves the nervous system, the immune system, the hormonal system, nutritional status, psychological state, and the biomechanical efficiency of the body as an integrated whole. Treating only the trigger point—without addressing spinal dysfunction, systemic inflammation, nutritional deficiencies, sleep disruption, and the structural and movement patterns that created it—is like patching a hole in a wall without fixing the underlying moisture problem. The patch may hold for a while, but the wall will keep deteriorating.

This is why our clinic exists as a multidisciplinary team:

• Jimenez’s chiropractic and functional medicine expertise addresses the structural and systemic roots of musculoskeletal dysfunction
• Cardenas’ internal medicine mastery ensures that every patient’s systemic health is optimized and medically managed to support healing
• Our TPI and interventional capabilities provide the targeted, immediate deactivation of pathological trigger points that allows patients to begin moving, healing, and rebuilding.
• Our rehabilitation and functional restoration programs re-educate the body in healthy movement patterns and build the muscular strength and endurance needed to prevent recurrenc.e
• Our personal injury services ensure that patients who have been injured through no fault of their own receive not only excellent clinical care but also the thorough documentation and advocacy they deserve

This is integrative medicine in the truest sense — not an administrative label or a marketing term, but a daily clinical reality in which multiple disciplines work together seamlessly toward the single shared goal of maximizing each patient’s health, function, and quality of life.

Summary and Clinical Takeaways

Key Principles of Trigger Point Therapy and Integrative Musculoskeletal Care

To conclude this comprehensive educational post, here are the foundational clinical takeaways from our discussion:

Understanding Trigger Points:

• Myofascial trigger points are hyperirritable nodules within taut bands of skeletal muscle, formed through a cascade of ACh dysregulation, sarcomere contracture, local ischemia, and inflammatory biochemical accumulation
• The Integrated Hypothesis (Simons et al.; Shah et al., 2008) provides the scientific framework explaining trigger point formation and persistence
• Microfibrotic adhesions within and around the trigger point perpetuate taut band formation and restrict normal muscle function

Injection Protocol:

• TPI with 1:1 lidocaine and Ceraferm provides both immediate chemical deactivation and sustained anti-inflammatory resolution of the trigger point locus
• Ceraferm (plant-derived anti-inflammatory) is preferred over corticosteroids for TPI due to its favorable safety profile and absence of the tissue-degenerative risks associated with repeated steroid injection
• Star pattern needling ensures comprehensive three-dimensional mechanical disruption of the taut band and surrounding adhesions
• Volume guidelines: 1 mL at cervical and upper thoracic sites; 2 mL at lower thoracic and lumbar sites
• Depth discipline: Never exceed 1 inch depth at cervical or upper thoracic sites; 1.5 inches introduces pneumothorax risk in thin patients
• Sequence injections from least to most severe to optimize patient tolerance and cooperation

Dry Needling and the Spectrum of Needle Therapies:

• Dry needling uses the same technique without injectate — equally valid for patients with lidocaine allergy or in settings without injectable medications
• TPI with Ceraferm produces superior results to dry needling alone by adding chemical deactivation and sustained anti-inflammatory activity
• PRP in trigger points is overkill — PRP is a regenerative therapy for structural tissue damage, not a functional neuromuscular dysfunction like a trigger point
• Prolotherapy and ozone are reserved for ligamentous and structural joint pathology

Chiropractic Integration:

• Vertebral subluxation and segmental dysfunction are neurological root causes of trigger point formation that must be addressed for lasting results
• Spinal manipulation normalizes gamma motor neuron tone and mechanoreceptor input, reducing the central neurological drive to muscle hypertonicity
• Combined TPI + chiropractic adjustment produces superior outcomes to either alone — physiologically logical and evidence-supported

Anatomy Is Non-Negotiable:

• Safe, effective TPI requires mastery of regional anatomy including muscle fiber direction, neurovascular proximity, and bony landmarks
• Revisit anatomy regularly — this knowledge is the foundation upon which safe practice rests

Functional Medicine and Perpetuating Factors:

• Magnesium, vitamin D, B12, iron, and CoQ10 deficiencies are among the most important nutritional perpetuating factors for myofascial pain
• Hormonal imbalances (hypothyroidism, estrogen deficiency, cortisol dysregulation) must be identified and treated
• Sleep optimization and stress management are essential components of comprehensive myofascial pain management
• Systemic inflammation from metabolic, gut, or autoimmune sources perpetuates central sensitization and must be addressed through functional medicine

The Multidisciplinary Team:

• Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST provides chiropractic care, TPI, functional medicine, and integrative clinical expertise
• Maria Guadalupe Cardenas, MD (Board Certified Internal Medicine, NPI #1164426749, Texas MD License #J2933) provides medical direction, internal medicine oversight, and collaborative care that ensures every patient receives medically sound, comprehensively managed care
• The combination of chiropractic, internal medicine, functional medicine, TPI, rehabilitation, and personal injury services in a single integrated clinic represents the highest standard of integrative musculoskeletal care currently available.le

References

• Bocci, V., Borrelli, E., Travagli, V., & Zanardi, I. (2011). The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Medicinal Research Reviews, 29(4), 646-682.
• Borg-Stein, J., & Simons, D. G. (2002). Focused review: Myofascial pain. Archives of Physical Medicine and Rehabilitation, 83(3 Suppl 1), S40-S49.
• Bronfort, G., Evans, R., Anderson, A. V., Svendsen, K. H., Bracha, Y., & Grimm, R. H. (2012). Spinal manipulation, medication, or home exercise with advice for acute and subacute neck pain. Annals of Internal Medicine, 156(1 Pt 1), 1-10.
• Campa-Moran, I., Rey-Gudin, E., Fernández-Carnero, J., Paris-Alemany, A., Gil-Martínez, A., Lerma Lara, S., Prieto-Baquero, A., Alonso-Pérez, J. L., & La Touche, R. (2020). Comparison of dry needling versus orthopedic manual therapy in patients with myofascial chronic neck pain: A single-blind, randomized pilot study. Evidence-Based Complementary and Alternative Medicine, 2015, 327307.
• Chen, J. T., Chen, S. M., Kuan, T. S., Chung, K. C., & Hong, C. Z. (2001). Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle. Archives of Physical Medicine and Rehabilitation, 79(7), 790-794.
• Cummings, T. M., & White, A. R. (2001). Needling therapies in the management of myofascial trigger point pain: A systematic review. Archives of Physical Medicine and Rehabilitation, 82(7), 986-992.
• Dommerholt, J. (2011). Dry needling — peripheral and central considerations. Journal of Manual & Manipulative Therapy, 19(4), 223-237.
• Edgelow, P. I. (2009). Neurovascular consequences of cumulative trauma disorders affecting the thoracic outlet. In R. Donatelli (Ed.), Physical Therapy of the Shoulder (5th ed., pp. 153-180). Churchill Livingstone.
• Fernandez-de-las-Penas, C., Dommerholt, J., & Gerwin, R. (2015). Myofascial pain and fibromyalgia syndromes. In Myofascial Pain and Fibromyalgia Syndromes: A Clinical Guide to Diagnosis and Management. Elsevier.
• Fishman, L. M., Dombi, G. W., Michaelsen, C., Ringel, S., Rozbruch, J., Rosner, B., & Weber, C. (2002). Piriformis syndrome: Diagnosis, treatment, and outcome — a 10-year study. Archives of Physical Medicine and Rehabilitation, 83(3), 295-301.
• Furlan, A. D., Brosseau, L., Imamura, M., & Irvin, E. (2005). Massage for low-back pain: A systematic review within the framework of the Cochrane Collaboration back review group. Spine, 27(17), 1896-1910.
• Gerwin, R. D. (2014). Diagnosis of myofascial pain syndrome. Physical Medicine and Rehabilitation Clinics of North America, 25(2), 341-355.
• Hong, C. Z. (1994). Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. American Journal of Physical Medicine & Rehabilitation, 73(4), 256-263.
• Kietrys, D. M., Palombaro, K. M., Azzaretto, E., Hubler, R., Schaller, B., Schlussel, J. M., & Tucker, M. (2013). Effectiveness of dry needling for upper-quarter myofascial pain: A systematic review and meta-analysis. Journal of Orthopedic & Sports Physical Therapy, 43(9), 620-634.
• Liu, L., Huang, Q. M., Liu, Q. G., Ye, G., Bo, C. Z., Chen, M. J., & Li, P. (2021). Effectiveness of dry needling for myofascial trigger points associated with neck and shoulder pain: A systematic review and meta-analysis. Journal of Pain Research, 14, 453-468.
• Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009). Lower plasma Coenzyme Q10 in depression: A marker for treatment resistance and chronic fatigue in depression and a risk factor for cardiovascular disorder in that illness. Neuro Endocrinology Letters, 30(4), 462-469.
• Melzack, R., & Wall, P. D. (1965). Pain mechanisms: A new theory. Science, 150(3699), 971-979.
• Nijs, J., Meeus, M., Cagnie, B., Roussel, N. A., Dolphens, M., Van Oosterwijck, J., & Danneels, L. (2014). A modern neuroscience approach to chronic spinal pain: Combining pain neuroscience education with cognition-targeted motor control training. Physical Therapy, 94(5), 730-738.
• Pasquier, M., Daneau, C., Marchand, A. A., & Descarreaux, M. (2018). Spinal manipulation frequency and dosage effects on clinical and physiological outcomes: A scoping review. Chiropractic & Manual Therapies, 27, 23.
• Rondón, L. J., Privat, A. M., Daulhac, L., Davin, N., Mazur, A., Fialip, J., Eschalier, A., & Rayssiguier, Y. (2017). Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. International Journal of Molecular Sciences, 11(12), 5239-5250.
• Rubinstein, S. M., Terwee, C. B., Assendelft, W. J., de Boer, M. R., & van Tulder, M. W. (2012). Spinal manipulative therapy for acute low-back pain. Cochrane Database of Systematic Reviews, 2012(9), CD008880.
• Shah, J. P., Danoff, J. V., Desai, M. J., Parikh, S., Nakamura, L. Y., Phillips, T. M., & Gerber, L. H. (2008). Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Archives of Physical Medicine and Rehabilitation, 89(1), 16-23.
• Simons, D. G., Travell, J. G., & Simons, L. S. (1999). Travell & Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual (2nd ed.). Williams & Wilkins.
• Sterling, M., Smeets, R., Keijzers, G., Warren, J., & Kenardy, J. (2019). Physiotherapist-delivered stress inoculation training integrated with exercise versus physiotherapy exercise alone for acute whiplash-associated disorder (StressModex): A randomized controlled trial of a psychologically informed approach. British Journal of Sports Medicine, 53(19), 1240-1247.
• Stisi, S., Venditti, C., Cazzola, M., Atzeni, F., Sarzi-Puttini, P., Bocchino, M., & Carmel, B. (2008). Etiopathogenic mechanisms of fibromyalgia syndrome. Reumatismo, 60(Suppl 1), 25-35.
• Straube, S., Derry, S., Moore, R. A., & McQuay, H. J. (2010). Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database of Systematic Reviews, 2010(1), CD007771.
• Travell, J. G., & Simons, D. G. (1999). Myofascial Pain and Dysfunction: The Trigger Point Manual (Vols. 1 & 2). Williams & Wilkins.
• Unverzagt, C., Berglund, K., & Thomas, J. J. (2015). Dry needling for myofascial trigger point pain: A clinical commentary. Journal of Manual & Manipulative Therapy, 23(1), 3-8.
• Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3 Suppl), S2-S15.

For appointments or consultations at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, or to learn more about our integrative clinical services, visit dralexjimenez.com or connect with Dr. Alex Jimenez on LinkedIn.

SEO Tags: trigger point injections, myofascial pain syndrome, dry needling El Paso, lidocaine trigger point injection, Ceraferm anti-inflammatory injection, integrative chiropractic care, Dr. Alex Jimenez DC, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, multidisciplinary pain management, chiropractic and internal medicine, functional medicine myofascial pain, central sensitization treatment, whiplash trigger points, cervical trigger points, lumbar trigger points, quadratus lumborum trigger points, piriformis syndrome, PRP versus trigger point injection, prolotherapy ozone PRP, spinal manipulation myofascial pain, star pattern trigger point injection, pneumothorax prevention injection, personal injury care El Paso, functional medicine El Paso, magnesium deficiency muscle pain, vitamin D myofascial pain, chiropractic functional medicine, trigger point anatomy, neuromuscular junction dysfunction, sarcomere contraction trigger point, Shah microdialysis trigger points, integrated hypothesis trigger points, evidence-based chiropractic, radiofrequency ablation pain management, cervicogenic headache treatment, chronic low back pain chiropractic, thoracic outlet syndrome trigger points, fibromyalgia integrative treatment, whiplash-associated disorders, personal injury documentation, internal medicine pain management, APRN chiropractic care, FNP-BC chiropractic, CFMP IFMCP functional medicine, sports injury rehabilitation El Paso, post-traumatic myofascial pain, central sensitization chronic pain, gate control theory manual therapy, wind-up dorsal horn sensitization